Sharma East India Hospitals & Medical Research Ltd Stock Price Today (NSE: SHARMEH)
Sharma East India Hospitals & Medical Research Ltd
Fundamental Score
Sharma East India Hospitals & Medical Research Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Sharma East India Hospitals & Medical Research Ltd share price today is ₹100.73, up +3.05% on NSE/BSE as of 7 August 2026. Sharma East India Hospitals & Medical Research Ltd (SHARMEH) is a Small-cap company in the Healthcare Service Provider sector with a market capitalisation of ₹31.66 (Cr). The 52-week high for SHARMEH share price is ₹233.90 and the 52-week low is ₹76.00. At a P/E ratio of 25.53x, SHARMEH is currently trading below its industry average P/E of 42.23x. The company has a Return on Equity (ROE) of 9.47% and a debt-to-equity ratio of 0.53.
Sharma East India Hospitals & Medical Research Ltd Share Price Chart — NSE/BSE Historical Performance
Sharma East India Hospitals & Medical Research Ltd share price chart: -2.40% return over the past month. 52-week high ₹233.90, 52-week low ₹76.00.
Sharma East India Hospitals & Medical Research Ltd — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹98.75 | ₹101.00 | ₹98.50 | ₹100.73 | 54.00 (Cr) | |
| ₹96.01 | ₹102.50 | ₹95.00 | ₹97.75 | 1.11K (Cr) | |
| ₹99.00 | ₹100.50 | ₹99.00 | ₹100.50 | 60.00 (Cr) | |
| ₹98.60 | ₹102.00 | ₹98.00 | ₹99.44 | 244.00 (Cr) | |
| ₹100.90 | ₹103.00 | ₹98.60 | ₹98.60 | 95.00 (Cr) | |
| ₹100.00 | ₹104.90 | ₹97.00 | ₹99.75 | 204.00 (Cr) | |
| ₹101.00 | ₹101.00 | ₹100.00 | ₹100.90 | 265.00 (Cr) | |
| ₹97.00 | ₹100.00 | ₹97.00 | ₹100.00 | 20.00 (Cr) | |
| ₹99.00 | ₹100.00 | ₹95.71 | ₹96.22 | 355.00 (Cr) | |
| ₹99.50 | ₹103.98 | ₹97.00 | ₹99.78 | 980.00 (Cr) |
Sharma East India Hospitals & Medical Research Ltd — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹100.90 | ₹103.00 | ₹95.00 | ₹100.73 | -0.17% | |
| ₹115.00 | ₹115.00 | ₹91.00 | ₹99.75 | -13.26% | |
| ₹101.20 | ₹119.70 | ₹95.10 | ₹97.70 | -3.46% | |
| ₹97.00 | ₹124.62 | ₹85.00 | ₹108.18 | +11.53% | |
| ₹106.95 | ₹114.00 | ₹85.60 | ₹95.85 | -10.38% | |
| ₹97.00 | ₹111.99 | ₹80.15 | ₹103.48 | +6.68% | |
| ₹111.00 | ₹129.90 | ₹86.70 | ₹98.85 | -10.95% | |
| ₹129.40 | ₹134.00 | ₹92.35 | ₹105.65 | -18.35% | |
| ₹139.55 | ₹150.50 | ₹118.25 | ₹130.70 | -6.34% | |
| ₹135.50 | ₹142.05 | ₹120.90 | ₹132.95 | -1.88% | |
| ₹153.45 | ₹172.90 | ₹134.70 | ₹138.25 | -9.91% | |
| ₹222.80 | ₹233.90 | ₹156.55 | ₹156.55 | -29.74% |
AI Research Briefing
Powered by Gemini · 2026-04-08
Micro-cap healthcare play with stagnant promoter holding and declining quarterly profit growth is a value trap.
WHAT'S HAPPENING NOW
No major catalysts found after live search. The trading window closed on March 27th for Q4 FY26 results.
CORE STORY
A micro-cap healthcare provider trading on hopes of outsized growth in a consolidating industry.
- Industry tailwinds
- Valuation discount to peers
- Potential acquisition target
- Strong Q4 FY26 results
- Acquisition by a larger player
- Significant order wins
- Micro-cap liquidity risk
- Declining YoY profit in the latest quarter (-5.88%)
- Dependence on a single hospital (Jaipur Hospital)
Promoter holding stagnant at 53.63%. No FII/DII interest.
Healthcare sector growth in India provides a tailwind, but increased competition and regulatory changes pose headwinds.
Profit converting to cash, with ₹9.1 Cr Free Cash Flow 5Y.
3-6 month thesis: Monitor Q4 FY26 results for signs of turnaround. Watch for any acquisition news. Without strong catalysts, expect continued underperformance.
Primary Thesis Risk
Micro-cap liquidity risk and declining profitability could lead to significant capital erosion.
For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Sharma East India Hospitals & Medical Research Ltd Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Sharma East India Hospitals & Medical Research Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of SHARMEH across key market metrics for learning purposes.
Positive Indicators
6 factors identified
Attractive Valuation (P/E: 25.53 vs Industry: 42.23)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity.
Strong Revenue Growth (24.92%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential.
Consistent Growth Track Record (34.61% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Strong Profit Growth Track Record (21.39% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Balanced Promoter Holding (53.63%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
2 factors identified
Below-Average Return on Equity (9.47%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Sharma East India Hospitals & Medical Research Ltd vs Healthcare Service Provider Peers
Peer Comparison - Healthcare Service Provider
Compare Sharma East India Hospitals & Medical Research Ltd with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
55.5/100 | ₹100.73₹101 | ₹31.66₹31.66 | 25.53Average 25.5 Average | 9.47%Poor 9.47% Poor | 11.58%Average 11.58% Average | 0.53Good 0.5 Good | 21.39%Excellent 21.39% Excellent | 34.61%Excellent 34.61% Excellent | 0.00% | |
Dr Lal PathLabs LtdDr Lal PathLabs... LALPATHLAB • 539524 | 57.7/100 | ₹1905.20₹1905 | ₹28908.91₹28908.91 | 55.39Average 55.4 Average | 22.30%Excellent 22.30% Excellent | 28.00%Excellent 28.00% Excellent | 0.08Excellent 0.1 Excellent | 12.33%Good 12.33% Good | 11.81%Good 11.81% Good | 0.81% |
Vijaya Diagnostic Centre LtdVijaya Diagnost... VIJAYA • 543350 | 67.8/100 | ₹1344.40₹1344 | ₹14307.85₹14307.85 | 82.71Average 82.7 Average | 19.74%Good 19.74% Good | 21.29%Excellent 21.29% Excellent | 0.44Excellent 0.4 Excellent | 15.47%Excellent 15.47% Excellent | 16.66%Excellent 16.66% Excellent | 0.14% |
Metropolis Healthcare LtdMetropolis Heal... METROPOLIS • 542650 | 57.9/100 | ₹582.45₹582 | ₹11858.49₹11858.49 | 60.38Average 60.4 Average | 13.81%Average 13.81% Average | 17.77%Good 17.77% Good | 0.15Excellent 0.1 Excellent | 1.46%Average 1.46% Average | 10.52%Good 10.52% Good | 0.35% |
Thyrocare Technologies LtdThyrocare Techn... THYROCARE • 539871 | 46.7/100 | ₹579.00₹579 | ₹8420.27₹8420.27 | 52.36Average 52.4 Average | 28.40%Excellent 28.40% Excellent | 35.38%Excellent 35.38% Excellent | 0.09Excellent 0.1 Excellent | 8.37%Good 8.37% Good | 10.88%Good 10.88% Good | 1.76% |
Krsnaa Diagnostics LtdKrsnaa Diagnost... KRSNAA • 543328 | 31.9/100 | ₹527.45₹527 | ₹1777.47₹1777.47 | 17.31Average 17.3 Average | 10.89%Average 10.89% Average | 12.70%Average 12.70% Average | 0.54Good 0.5 Good | -11.13%Poor -11.13% Poor | 11.75%Good 11.75% Good | 0.50% |
Suraksha Diagnostic LtdSuraksha Diagno... SURAKSHA • 544293 | 56.2/100 | ₹252.15₹252 | ₹1359.30₹1359.30 | 42.23Average 42.2 Average | 14.12%Average 14.12% Average | 16.97%Good 16.97% Good | 0.53Good 0.5 Good | 31.68%Excellent 31.68% Excellent | 17.26%Excellent 17.26% Excellent | 0.00% |
One Global Service Provider IncOne Global Serv... ONEGLOBAL • 514330 | 82.2/100 | ₹564.95₹565 | ₹1178.25₹1178.25 | 16.95Average 16.9 Average | 65.27%Excellent 65.27% Excellent | 87.02%Excellent 87.02% Excellent | 0.00Excellent 0.0 Excellent | 97.21%Excellent 97.21% Excellent | 167.02%Excellent 167.02% Excellent | 0.00% |
3B Blackbio Diagnostics Ltd3B Blackbio Dia... 3BBLACKBIO • 532067 | 60.3/100 | ₹1248.10₹1248 | ₹1079.13₹1079.13 | 18.42Average 18.4 Average | 19.77%Good 19.77% Good | 25.48%Excellent 25.48% Excellent | 0.01Excellent 0.0 Excellent | -12.44%Poor -12.44% Poor | -8.95%Poor -8.95% Poor | 0.31% |
Sastasundar Ventures LtdSastasundar Ven... SASTASUNDR • 533259 | 39/100 | ₹301.45₹301 | ₹1035.54₹1035.54 | 539.34Average 539.3 Average | 0.29%Poor 0.29% Poor | -0.05%Poor -0.05% Poor | 0.04Excellent 0.0 Excellent | 16.91%Excellent 16.91% Excellent | 19.09%Excellent 19.09% Excellent | 0.00% |
49.4/100 | ₹239.10₹239 | ₹600.78₹600.78 | 20.55Average 20.6 Average | 19.92%Good 19.92% Good | 23.27%Excellent 23.27% Excellent | 0.31Excellent 0.3 Excellent | — — | — — | 0.00% | |
Top Healthcare Service Provider Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Dr Lal PathLabs Ltd share price28908.91 Cr
- Vijaya Diagnostic Centre Ltd share price14307.85 Cr
- Metropolis Healthcare Ltd share price11858.49 Cr
- Thyrocare Technologies Ltd share price8420.27 Cr
- Krsnaa Diagnostics Ltd share price1777.47 Cr
Sharma East India Hospitals & Medical Research Ltd Quarterly Performance
Latest quarterly metrics for SHARMEH — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
24.92%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
16.22%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
34.61%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
21.39%
Compounded annual net profit growth over 5 years
Sharma East India Hospitals & Medical Research Ltd Technical Indicators
SMA 50, SMA 200, RSI and volume signals for SHARMEH — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Sharma East India Hospitals & Medical Research Ltd Financial Statements
Annual income statement, balance sheet and cash flow for Sharma East India Hospitals & Medical Research Ltd (SHARMEH) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for Sharma East India Hospitals & Medical Research Ltd
About SHARMEH (Sharma East India Hospitals & Medical Research Ltd)
Sharma East India Hospitals & Medical Research Ltd is a pioneering healthcare institution deeply rooted in the vibrant landscape of Jaipur, India. Since its inception in 1989, the ...organization has diligently cultivated a reputation for delivering comprehensive and compassionate medical care to the communities it serves. Operating under the esteemed banner of Jaipur Hospital, SHARMEH has steadily evolved into a trusted name synonymous with quality and accessibility in the East Indian healthcare sector. More than just a facility, SHARMEH stands as a beacon of hope, embracing a patient-centric approach that prioritizes individual well-being and strives to create a healing environment. SHARMEH embodies a multi-specialty approach, integrating a wide spectrum of medical disciplines to cater to the diverse needs of its patients. From advanced diagnostic procedures and cutting-edge surgical interventions to specialized rehabilitation therapies and personalized wellness programs, SHARMEH offers a holistic continuum of care under one roof. The organization's commitment to innovation is evident in its continuous investment in state-of-the-art technology and the cultivation of a highly skilled medical team composed of experienced physicians, nurses, and allied healthcare professionals. The hospital's unwavering dedication to excellence ensures that patients receive the most effective and contemporary treatments available. SHARMEH's influence extends far beyond the confines of its physical location, contributing significantly to the advancement of medical research and education within the region. Through its active engagement in clinical trials and collaborative research initiatives, the hospital plays a crucial role in shaping the future of healthcare practices. Moreover, SHARMEH is dedicated to fostering a culture of continuous learning, providing training opportunities for aspiring medical professionals and empowering its staff to stay at the forefront of medical breakthroughs. Ultimately, Sharma East India Hospitals & Medical Research Ltd aims to be a catalyst for positive change, elevating healthcare standards and improving the lives of individuals across East India.
Company Details
Key Leadership
Corporate Events
SHARMEH Share Price: Frequently Asked Questions
What is the current share price of Sharma East India Hospitals & Medical Research Ltd?
Sharma East India Hospitals & Medical Research Ltd (SHARMEH) trades at ₹100.73 on NSE and BSE. Market cap ₹31.66 (Cr). Educational data only.
What is the P/E ratio of Sharma East India Hospitals & Medical Research Ltd?
Sharma East India Hospitals & Medical Research Ltd has a P/E of 25.53x vs industry average 42.23x.
What is the Bull Run score for Sharma East India Hospitals & Medical Research Ltd?
Sharma East India Hospitals & Medical Research Ltd has a Bull Run score of 55.5/100 based on 25+ financial parameters.
Does Sharma East India Hospitals & Medical Research Ltd pay dividends?
Sharma East India Hospitals & Medical Research Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of Sharma East India Hospitals & Medical Research Ltd?
Sharma East India Hospitals & Medical Research Ltd has ROE of 9.47%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Sharma East India Hospitals & Medical Research Ltd?
Sharma East India Hospitals & Medical Research Ltd has debt-to-equity of 0.53.
Is Sharma East India Hospitals & Medical Research Ltd a good investment?
Bull Run gives Sharma East India Hospitals & Medical Research Ltd a score of 55.5/100. This is not investment advice — consult a SEBI-registered advisor.